(Alliance News) - Stock prices in London came to a mixed closed on Monday, as the FTSE 100 underperformed its European peers, while the domestically-focused FTSE 250 index saw a stronger day. Read More
(Alliance News) - The FTSE 100 stood out on Monday, but for the wrong reason, as share price falls for some of its largest constituents meant the index London large-caps underperformed versus the mid-cap FTSE 250 and European indices. Read More
(Alliance News) - GSK PLC on Monday said that its blood cancer drug, Blenrep, has failed to meet its primary endpoint of progression-free survival in recent phase three trials. Read More
(Alliance News) - AstraZeneca PLC on Friday said its respiratory syncytial virus treatment Beyfortus, or nirsevimab, which it develops with Sanofi SA, has received EU approval for prevention of the virus in newborns and infants. Read More
(Alliance News) - GSK PLC on Thursday said it was stopping enrolment for its gepotidacin antibiotic trial early, following a recommendation by the Independent Data Monitoring Committee. Read More
(Alliance News) - Stock prices in London edged into the red at midday on Wednesday, as the market awaited a key US interest rate decision, but welcomed positive business updates from GSK and Next. Read More
(Alliance News) - GSK PLC on Wednesday raised its 2022 guidance and said its respiratory syncytial virus older adult vaccine candidate has been granted priority review by the US Food & Drug Administration. Read More
(Alliance News) - Trading was timid in London at the market open on Wednesday, after a series of mixed corporate updates, as investors awaited the all-important interest rate decision from the US Federal Reserve, due after the European close. Read More
(Alliance News) - Stock prices in London were called slightly higher on Wednesday, as investors awaited the all-important interest rate decision to come from the US Federal Reserve. Read More
(Alliance News) - Haleon PLC on Monday announced the pricing for offers to exchange six series of outstanding unregistered notes issued by GSK Consumer Healthcare Capital US LLC and one series by GSK Consumer Healthcare Capital UK PLC due between 2024 and 2052, which Haleon announced on September 29. Read More
(Alliance News) - Stocks in London closed in the red on Friday, but clung on for week gains, as interest rate decisions from the Bank of England and the US Federal Reserve move into focus. Read More
(Alliance News) - GSK PLC on Friday said its majority owned ViiV Healthcare venture has received the European Medicines Agency's validation for its marketing authorisation application for HIV prevention, and said its MAA for respiratory syncytial virus adult vaccine has also been accepted. Read More
(Alliance News) - GSK PLC on Thursday said a US Food & Drug Administration panel has supported daprodustat for adults on dialysis but not for non-dialysis adults, and provided an update on the ContRAst phase III programme for otilimab. Read More
Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - In the year ended June 30, pretax loss widens to GBP2.6 million from GBP1.7 million a year before. No revenue is recorded in either year, but in the previous year it brought in GBP171,000 in other operating income, with none recorded for financial 2022. Says it will discuss the future of SRA737 with partner Cancer Research Technology Pioneer Fund. Earlier this month, GSK PLC subsidiary Sierra Oncology Inc said it intends to return the rights for the SRA737 cancer treatment to CPF. Read More
(Alliance News) - GSK PLC on Friday said that a new drug application for its respiratory syncytial virus vaccine candidate has been accepted for review by the Japanese Ministry of Health, Labour & Welfare. Read More
(Alliance News) - GSK PLC on Monday said the meningitis vaccine Menveo has been approved by the US Food & Drug Administration in a single-vial presentation to help prevent disease caused by meningococcal bacteria serogroups A, C, Y, and W. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More
(Alliance News) - GSK PLC on Thursday announced a vast decline in severe respiratory syncytial virus, or RSV, disease among people aged 60 years and older who were vaccinated with its RSV vaccine candidate. Read More
(Alliance News) - Sareum Holdings PLC on Wednesday after Sierra Oncology Inc, a subsidiary of GSK PLC, said it intends to return the rights for SRA737 to the CRT Pioneer Fund LP. Read More